triamcinolone has been researched along with Bacterial Eye Infections in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dhaliwal, DK; Kowalski, RP; Mammen, A; Romanowski, EG; Shanks, RMQ | 1 |
| Bond, WI; Brown, JA; Hahn, JM; Kishore, K; Satar, JM | 1 |
| Chalam, KV; Ng, C | 1 |
| Banta, JT; Flynn, HW; Schimel, AM; Stringham, JD | 1 |
| Flynn, HW; Schwartz, SG; Scott, IU | 1 |
| Cardillo, JA; Melo, LA; Oliveira, AG; Paganelli, F; Pizzolitto, AC; Silva, AA | 1 |
| Ahn, J; Chung, H; Han, JM; Heo, JW; Park, KH; Park, KU; Song, J; Woo, SJ; Yu, HG | 1 |
1 review(s) available for triamcinolone and Bacterial Eye Infections
| Article | Year |
|---|---|
Endophthalmitis after intravitreal injections.
Topics: Anti-Bacterial Agents; Clinical Protocols; Coagulase; Diagnosis, Differential; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Staphylococcus; Triamcinolone; Visual Acuity; Vitreous Body | 2009 |
6 other study(ies) available for triamcinolone and Bacterial Eye Infections
| Article | Year |
|---|---|
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Intravitreal Injections; Male; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone | 2018 |
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Phacoemulsification; Retrospective Studies; Surgical Wound Infection; Triamcinolone | 2018 |
Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Combinations; Drug Implants; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin, Dexamethasone Drug Combination; Triamcinolone; Vancomycin; Vitrectomy | 2020 |
Dropless Cataract Surgery: What Are the Potential Downsides?
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Lens Implantation, Intraocular; Moxifloxacin; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Risk Factors; Triamcinolone; Vancomycin | 2016 |
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Ciprofloxacin; Conjunctiva; Delayed-Action Preparations; Drug Carriers; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone; Vitreous Body | 2010 |
Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bacteria; Bevacizumab; Drug Administration Schedule; Drug Contamination; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Ranibizumab; Retinal Diseases; Retrospective Studies; RNA, Ribosomal, 16S; Sensitivity and Specificity; Triamcinolone | 2012 |